2m 2m 2m 2m 2m 2m 2m
Q32 BIO (QTTB)
NASDAQ
$12.10+$0.22 (+1.84%)
Price as of Jun 23, 2026 7:55 PM EDT- $214.5MMarket Cap
- 647.17%1-Year Change
- BiotechnologyIndustry
Q32 BIO (QTTB)
$12.10+$0.22 (+1.84%)
QTTB | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $11.88 | ||
Change | -$0.77 (-6.09%) | ||
Open | $12.60 | ||
High | $13.09 | ||
Low | $11.70 | ||
Previous Close | $12.65 | ||
Volume | 384,999 | ||
30-Day Average Volume | 1,656,399 | ||
1-Week Change | -6.82% | ||
1-Month Change | 104.83% | ||
1-Year Change | 647.17% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 17.0M | ||
Total Assets | $63.7M | ||
Market Cap | $214.5M | ||
Enterprise Value | $171.9M | ||
Period: QTR TTM FY | |||
Revenue | -$192,000.00 | ||
Net Income | -$7.6M | ||
Free Cash Flow | -$6.3M | ||
EBIT | -$7.4M | ||
EBITDA | -$7.3M | ||
Net Working Capital | $46.5M | ||
EPS | -$0.54 | ||
Enterprise Value/EBITDA | -23 | ||
Enterprise Value/Revenue | -895 | ||
P/B | 5 | ||
P/E | -23 | ||
PEG | 0 | ||
Price/Free Cash Flow | -34 | ||
Price/Operating Cash Flow | -34 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue